Alumni Ventures Group, LLC is a venture capital firm based in Manchester, New Hampshire, founded in 2013. The firm specializes in seed and early-stage investments, as well as late-stage pre-IPO opportunities, with a flexible approach that is sector and geographic agnostic. Alumni Ventures aims to provide high-quality, diversified venture portfolios to individual investors, particularly accredited alumni from top entrepreneurial schools, who may not have had access to venture capital previously. The firm focuses on backing companies that have an alumni connection and are led by established institutional investors with expertise in their respective fields. Additionally, Alumni Ventures offers focused funds that enable accredited investors to access a diverse portfolio of investments across various types, sectors, stages, and geographies.
Senior Associate, Seed Fund and Doctors Innovate Fund
Drew Wandzilak
Senior Associate, Green D and Yard and Strategic Tech Fund
Sarah Worden
Venture Scout
Ray Wu
Managing Partner-Web3 / Blockchain Fund
Michael Yuann
Director of Investment Operations
Past deals in Health Diagnostics
Epicore Biosystems
Series B in 2025
Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company founded in 2017 that specializes in developing and commercializing a wearable microfluidic sensing platform. This innovative technology analyzes small droplets of sweat directly from the skin to provide insights into health, hydration, and athletic performance. The platform is designed to measure various biomarkers, including proteomics and inflammatory markers, allowing for personalized management of health and nutrition. Epicore's approach leverages over two decades of research in microfluidics and soft materials conducted by leading experts at Northwestern University. By offering a non-invasive and cost-effective solution, Epicore aims to enhance athletic performance and improve overall health monitoring for users.
MetaSight Diagnostics
Series A in 2024
MetaSight Diagnostics, a health technology company, is on a mission to develop affordable and precise liquid biopsy diagnostics for the early detection of a wide range of chronic and acute diseases by leveraging proprietary mass spectrometry technologies (metabolomics, lipidomics, and proteomics).
Centaur Labs
Series B in 2024
Centaur Labs specializes in medical data annotation services, aimed at enhancing medical decision-making and diagnostics. The company utilizes a platform that connects a global network of students and professionals, who compete to provide high-quality data labeling. This collaborative model ensures exceptional accuracy and scalability in annotating medical and scientific data. By analyzing medical cases and labeling data effectively, Centaur Labs contributes to the development of advanced medical AI technologies, ultimately helping patients achieve better healthcare outcomes while potentially reducing costs.
Hopscotch Primary Care
Series C in 2024
Operator of a data-driven healthcare startup intended to transform healthcare in rural communities through exceptional care, bringing better access and quality service to its patients. The company delivers tailored quality care through a team-based model, with resources and support for patients, inside and outside clinics, thereby enabling healthcare professionals to provide the support and care that patients need.
Oula Health
Series B in 2024
Oula Health, Inc. specializes in maternity care services, offering both in-clinic and home-based prenatal care. Founded in 2019 and located in Brooklyn, New York, Oula aims to transform the maternity care experience by integrating obstetrics and midwifery. The company focuses on providing a personalized and evidence-based approach to pregnancy, combining modern medical practices with a compassionate understanding of human needs. Through its innovative maternity center, Oula sets a new standard for pregnancy care that emphasizes both medical expertise and personal connection.
Hallow
Series C in 2024
Hallow is a Catholic prayer and meditation app that hopes to help folks grow closer to God. It helps in finding peace, deepen the relationship with God, and sleeping soundly every night. It was founded in 2018 and is based in Chicago, Illinois.
Alvee
Seed Round in 2024
Alvee is a developer of an artificial intelligence-driven tool designed to enhance health equity and improve health outcomes for patients. The tool offers real-time, patient-specific alerts that notify healthcare providers and payers when a patient has a confirmed or potential health equity issue. By integrating social determinants of health, chronic conditions, demographic information, and health inequity risks, Alvee provides a comprehensive view of a patient's health equity status. This enables healthcare providers and payers to meet data stratification quality reporting requirements effectively.
Epicore Biosystems
Venture Round in 2024
Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company founded in 2017 that specializes in developing and commercializing a wearable microfluidic sensing platform. This innovative technology analyzes small droplets of sweat directly from the skin to provide insights into health, hydration, and athletic performance. The platform is designed to measure various biomarkers, including proteomics and inflammatory markers, allowing for personalized management of health and nutrition. Epicore's approach leverages over two decades of research in microfluidics and soft materials conducted by leading experts at Northwestern University. By offering a non-invasive and cost-effective solution, Epicore aims to enhance athletic performance and improve overall health monitoring for users.
Emm
Seed Round in 2023
Emm is focused on creating innovative consumer health tools that empower individuals to manage their health effectively. The company has developed a wearable device aimed at enhancing reproductive health by providing users with biometric data that offers actionable insights into their unique reproductive profiles. This technology enables users and their healthcare providers to identify potential health issues and optimize reproductive health outcomes, thereby improving the overall quality of life. Emm's approach combines advanced technology with specialized knowledge to enhance personal health management.
Ellipsis Health
Series A in 2023
Ellipsis Health, Inc. is a technology company based in San Francisco, California, founded in 2013. It specializes in developing analytics solutions that utilize artificial intelligence to enhance behavioral health assessments by analyzing patient speech and clinical data. The company's platform offers a behavioral biomarker technology that generates clinical-grade evaluations of anxiety and depression severity, as well as sub-clinical assessments of stress. This innovative approach allows healthcare systems to continuously monitor their patient populations for mental health conditions, particularly depression, and facilitates timely support for patients in need. By integrating affective computing into patient and care team interactions, Ellipsis Health aims to create real-time behavioral health vital signs for improved patient outcomes.
Ossium Health
Series C in 2023
Ossium Health, Inc. is engaged in the development and manufacturing of cell therapy products aimed at treating leukemia, other blood cancers, and tissue damage, as well as addressing radiation poisoning. The company offers a range of innovative therapies, including HPC, Marrow, which features HLA-matched bone marrow stem cells for hematopoietic reconstitution in blood cancer patients; Chimera, which enhances organ transplantation; and Chymalis, composed of mesenchymal stem cells that promote the healing of damaged bone and muscle tissue. Additionally, Ossium provides bone marrow cells for research purposes in oncology and immunology. Founded in 2016 and headquartered in San Francisco, California, Ossium Health focuses on improving health outcomes and longevity through advanced bioengineering techniques.
3X Genetics
Pre Seed Round in 2023
3X Genetics specializes in developing medical screening solutions aimed at identifying genetic disorders, particularly in infants and children. The company's technology focuses on screening for conditions such as myotonic dystrophy and other trinucleotide repeat disorders that lead to progressive muscle weakness. By offering these medical technologies, 3X Genetics enables healthcare professionals to proactively identify potential genetic issues, ultimately helping to prevent the birth of children affected by genetic diseases.
MedScout
Seed Round in 2023
MedScout is a revenue acceleration platform tailored for medical device and diagnostic companies. It offers sales enablement software that integrates medical claims intelligence from both public and private payors, providing users with critical insights into market dynamics. The platform is designed to assist sales professionals and leaders by delivering data on patient demographics, procedure volumes, referral patterns, and payment information. This functionality allows clients to conduct thorough market analysis, develop effective strategies, and enhance sales execution, ultimately optimizing operational productivity and fostering growth in their respective territories.
Mend
Series A in 2023
MEND is a life sciences company dedicated to advancing health and recovery through targeted clinical nutrition and medical food interventions. The company focuses on researching and developing products that enhance patient outcomes in various contexts, including injury recovery, surgical recovery, aging, and physical performance. MEND's solutions have been widely adopted by hospitals, health systems, and professional sports teams across major leagues, as well as by the elite forces of the US Military. Through its commitment to ongoing research and development, MEND aims to empower caregivers and improve health outcomes for individuals facing diverse health challenges.
DropStat
Venture Round in 2023
DropStat is a technology company that offers an app-based platform designed to optimize staffing for hospitals. Founded in 2017 and headquartered in Beverly Hills, California, DropStat utilizes artificial intelligence and machine learning to predict and autonomously fill staffing gaps, allowing healthcare facilities to manage labor costs more effectively. By streamlining the process of calling staff for open shifts, the platform eliminates the need for traditional communication methods such as calls and texts, thereby enhancing efficiency and reducing financial waste. In addition to improving operational processes, DropStat prioritizes data security, ensuring that sensitive information is protected both in the system and during transmission. The company's mission is to modernize shift communication, ultimately aiming to enhance both patient and staff satisfaction.
Pathfinder Health
Seed Round in 2023
Pathfinder Health is focused on enhancing child development for children aged 0-5 through its evidence-based clinical tool. This pediatric application aids parents and caregivers in monitoring developmental milestones, encouraging cognitive, physical, social, emotional, and communication growth through play. It facilitates communication with healthcare providers, allowing for earlier diagnoses of potential developmental issues. The app offers step-by-step guidance tailored to a child's current stage of development and connects users to additional resources, including developmental activities, articles, parenting tips, and local early intervention services. By providing these tools, Pathfinder Health empowers families to track their child's progress and seek timely intervention when necessary.
Oula Health
Series A in 2023
Oula Health, Inc. specializes in maternity care services, offering both in-clinic and home-based prenatal care. Founded in 2019 and located in Brooklyn, New York, Oula aims to transform the maternity care experience by integrating obstetrics and midwifery. The company focuses on providing a personalized and evidence-based approach to pregnancy, combining modern medical practices with a compassionate understanding of human needs. Through its innovative maternity center, Oula sets a new standard for pregnancy care that emphasizes both medical expertise and personal connection.
Koala Health
Series A in 2022
Koala Health is a Boston-based company founded in 2021 that specializes in providing medications and health products for pets. The company simplifies pet care by verifying and fetching prescriptions from veterinarians, sorting and packaging medications by date and time, and offering free delivery and refills. By focusing on vet-approved medications and supplements, Koala Health aims to enhance the quality of life for pets and support pet owners in managing their pets' health needs effectively.
Nanopath
Series A in 2022
Nanopath Inc. is a molecular diagnostics company focused on enhancing women's health through rapid and precise testing. By utilizing advancements in bioengineering and nanotechnology, the company specializes in the sensitive detection of viral, bacterial, and fungal pathogens without relying on nucleic acid amplification techniques. This innovative approach allows for the delivery of granular and clinically actionable information, thereby improving traditional testing methodologies and enabling healthcare providers to make informed decisions more swiftly.
Health Note
Series A in 2022
Health Note is an AI chatbot platform that streamlines the process of collecting patient information and creating physician notes, thereby enhancing clinic workflows. Founded in 2018 and based in San Francisco, California, the platform allows patients to engage in their own care by providing pre-visit information through a simple SMS link, eliminating the need for app downloads or sign-ins. This frictionless, platform-agnostic solution integrates seamlessly with electronic medical record systems, facilitating the documentation of physician-patient interactions and improving overall healthcare efficiency.
Boulder Care
Series B in 2022
Boulder Care, Inc. is a telemedicine-based platform focused on treating opioid addiction through a combination of medication and peer support. Founded in 2017 and located in Portland, Oregon, the company provides comprehensive services that include patient support, medication management, and psychosocial services. By leveraging digital health technology, Boulder Care aims to improve access to effective treatment for individuals struggling with opioid use, enhancing the experience for both patients and their care teams. The organization serves a diverse clientele, including patients, providers, and various health organizations, contributing to the advancement of the behavioral health industry.
Nextiles
Seed Round in 2022
Nextiles is a New York-based company founded in 2019 that specializes in smart apparel technology, merging athletic clothing with an advanced analytics system to enhance exercise performance and safety. The company innovatively integrates electrically conductive fibers into fabrics using a patented sewing technology, allowing for the development of wearables that include motion sensors directly within the apparel. This unique approach enables the creation of responsive and adaptive devices, providing valuable insights into an individual's movement patterns. With a strong foundation in electrical engineering and circuit design, Nextiles offers its expertise to businesses looking to develop or enhance their own Internet of Things (IoT) and smart device products.
Oobli
Series B in 2022
Oobli specializes in the development of healthy, protein-based sweeteners sourced from exotic plants. These unique compounds offer a flavorful experience without the calories typically associated with sugar, making them a suitable alternative for health-conscious consumers. The protein sweeteners are produced through fermentation, ensuring they have no glycemic impact and do not disrupt the gut microbiome. Oobli has successfully obtained regulatory approvals, including FDA "no questions" letters and GRAS status for several of its proteins, reinforcing their commitment to safety and quality. By providing a delicious and low-calorie option, Oobli aims to transform the way individuals approach sweeteners, allowing for healthier choices in everyday consumption.
NeuraLight
Series A in 2022
NeuraLight is a venture-backed company focused on improving the lives of individuals affected by neurological disorders through digital solutions. The company has developed a digital neurology platform that utilizes a proprietary, de-identified oculometric database. This technology allows for the analysis of eye movement using standard smartphones or webcams, enabling clinicians to effectively differentiate between patients and healthy individuals, categorize various subgroups, and track disease progression. By digitizing evaluation and care, NeuraLight aims to enhance diagnostic accuracy and treatment for those impacted by neurological conditions.
Health Hero
Seed Round in 2022
Health Hero, Inc. is a wellness platform that focuses on enhancing employee well-being and engagement for organizations worldwide. Founded in 2014 and headquartered in Tampa, Florida, the company provides a range of services, including health risk assessments, cultural assessments, and biometric screenings, accessible through mobile devices and computers. Health Hero's platform is designed to foster a positive workplace environment by integrating gamification elements, allowing employees to earn rewards for achieving wellness milestones. The platform supports over 14,000 companies and communities, reaching more than 5 million users and managing over 5 billion health data points. With a commitment to improving wellness options for employees and their families, Health Hero leverages advanced technology to drive engagement and support sustainable organizational growth.
Epicore Biosystems
Series A in 2022
Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company founded in 2017 that specializes in developing and commercializing a wearable microfluidic sensing platform. This innovative technology analyzes small droplets of sweat directly from the skin to provide insights into health, hydration, and athletic performance. The platform is designed to measure various biomarkers, including proteomics and inflammatory markers, allowing for personalized management of health and nutrition. Epicore's approach leverages over two decades of research in microfluidics and soft materials conducted by leading experts at Northwestern University. By offering a non-invasive and cost-effective solution, Epicore aims to enhance athletic performance and improve overall health monitoring for users.
Curbside Health
Seed Round in 2022
Curbside Health develops clinical decision support software that aligns health systems and clinicians to more efficiently deliver optimal care. The company was founded by physicians and technologists to combine the best of clinical evidence with the realities of healthcare delivery and with opportunities of modern web technology. We support health systems and hospitals to expand their clinical content library (e.g. clinical pathways, protocols, guidelines, A3s, checklists, etc) and enhance the utilization of these resources at the point-of-care. Together, the components of Curbside's platform enable a hospital to improve clinical outcomes and operational efficiencies. Product development is informed by working closely with patients, clinicians, engineers, physicians, healthcare administrators, and payors. Our mission is hiding in plain sight within our name, and those in healthcare will understand: every medical decision is informed in real-time by the world's expert of that particular situation, while simultaneously accounting for hospital policy and all relevant patient-specific data. Essentially, Curbside is on a never-ending quest to perfect medical decision making.
Insiteflow
Seed Round in 2021
Insiteflow is a company based in Austin, Texas, that specializes in an integrated electronic health record (EHR) platform designed to enhance clinical decision-making. Founded in 2018 by Anthony Gerardi and Corey Hall, the platform aims to improve clinical workflows by providing point-of-care insights that support better decision-making and treatment planning for patients. Insiteflow's technology focuses on automating EHR workflows to increase user adoption, efficiency, and effectiveness, while also capturing the decisions made by clinicians and staff within EHR databases. This approach allows healthcare professionals to drive improvements at critical decision points, ultimately transforming the results and return on investment from existing analytics and EHR systems.
Gordy Health
Convertible Note in 2021
Gordy Health is a virtual care provider specializing in blood pressure management to reduce the risk of serious health complications such as heart attacks, strokes, and kidney failure. Founded in 2021 and headquartered in Pasadena, California, the company offers a healthcare platform that allows users to manage their blood pressure from home. This platform provides direct access to heart specialists, facilitates easy scheduling of virtual appointments, and includes features such as real-time diagnostics, prescription delivery, and continuous monitoring and medication adjustments. By focusing on proactive management of high blood pressure, Gordy Health aims to help individuals lead healthier lives and extend their longevity.
Olaris
Series B in 2021
Olaris is dedicated to transforming disease diagnosis and treatment through its innovative CEREBRO platform, which integrates metabolomics and machine learning. This platform focuses on the Comprehensive Early Responsive Evaluation of Biomarkers Related to Outcomes, enabling the identification of biomarkers that can optimize patient treatment. By developing the myOLARIS™ precision diagnostics, Olaris aims to match the right drug to the right patient, enhancing clinical outcomes while minimizing adverse events. Founded in 2013 and headquartered in Framingham, Massachusetts, the company collaborates with healthcare providers to improve patient care through advanced diagnostic solutions.
GritWell
Seed Round in 2021
GritWell Ltd is a digital health platform established in 2018, based in San Francisco, California. The company focuses on addressing chronic health conditions by shifting the emphasis from symptom management to identifying and treating root causes. GritWell connects patients suffering from various chronic symptoms, such as insomnia, migraines, digestive issues, anxiety, and joint pain, with nutritionists, health coaches, and holistic practitioners. Its platform offers personalized care through clinically validated symptom assessments and facilitates secure video consultations, direct messaging, and an online portal for scheduling and managing patient records. By integrating natural treatments and providing tailored treatment plans, GritWell aims to enhance patient outcomes and support a holistic approach to health.
AdaptX
Series A in 2021
AdaptX is a healthcare data analytics and AI company that specializes in enhancing clinical and workflow outcomes for hospitals and surgery centers. Founded in Seattle in 2016 as a spin-off from Seattle Children's Hospital, AdaptX provides a platform that enables medical leaders and clinicians to access and analyze clinical data effectively. The platform integrates algorithms with existing electronic data systems, allowing healthcare providers to monitor performance, compare treatment approaches, and define patient cohorts. Through automated analytics, AdaptX helps healthcare service providers improve the quality and safety of care while also reducing costs.
Moons
Series A in 2021
Moons is a healthcare technology company based in Mexico City that specializes in orthodontic and dental hygiene products. Founded in 2019, the company offers innovative dental services, including the creation of personalized invisible aligners designed for each patient. Customers can visit Moons Studios for an initial consultation, where their teeth are scanned to develop a tailored treatment plan. Moons then manufactures and mails a set of 3D-printed aligners, allowing clients to straighten and whiten their teeth without the use of traditional braces. This process typically enables patients to achieve their desired smile in approximately six months, making orthodontic care more accessible and convenient.
Zone7
Convertible Note in 2021
Zone7 is a technology company founded in 2017 and based in Palo Alto, California, specializing in artificial intelligence-driven sports injury prediction software. The platform leverages data from wearable devices, medical records, and fitness profiles to forecast potential injuries, allowing for proactive measures to enhance athlete safety and performance. Zone7 serves over 30 professional sports franchises, offering insights that enable coaching staff to monitor athlete performance and injury risk effectively. Additionally, the technology is utilized in hospitals to ensure the well-being of medical staff by providing actionable recommendations for optimizing workload and recovery. By analyzing various data sources, Zone7 aims to protect and enhance the health and performance of both athletes and the elite workforce.
Future Family
Series A in 2021
Future Family, Inc. is a subscription-based fertility company founded in 2016 and headquartered in San Francisco, California. It provides comprehensive healthcare solutions for individuals and couples navigating fertility challenges, offering plans that cover all associated costs. The company's services include personalized fertility planning, clinic matching, and a dedicated nurse concierge, ensuring 24/7 access to a care team. Future Family specializes in on-demand medical support for procedures such as in vitro fertilization (IVF) and egg freezing, and it features a digital health platform for managing fertility care. By combining financial assistance with expert guidance, Future Family aims to deliver a stress-free fertility experience for its clients.
Insiteflow
Seed Round in 2021
Insiteflow is a company based in Austin, Texas, that specializes in an integrated electronic health record (EHR) platform designed to enhance clinical decision-making. Founded in 2018 by Anthony Gerardi and Corey Hall, the platform aims to improve clinical workflows by providing point-of-care insights that support better decision-making and treatment planning for patients. Insiteflow's technology focuses on automating EHR workflows to increase user adoption, efficiency, and effectiveness, while also capturing the decisions made by clinicians and staff within EHR databases. This approach allows healthcare professionals to drive improvements at critical decision points, ultimately transforming the results and return on investment from existing analytics and EHR systems.
Hydrow
Series C in 2021
Hydrow Inc., established in 2017 and based in Cambridge, Massachusetts, specializes in manufacturing high-end virtual rowing machines for home workouts. The company's flagship product, Hydrow, offers users an immersive rowing experience akin to being on the water, complete with adjustable resistance, real-time visuals, and audio, guided by expert instructors via on-demand digital courses. Hydrow sells its products directly to consumers through its online platform.
FULLFILL
Seed Round in 2021
FULLFILL is a digital health platform focused on providing virtual health coaching aimed at treating and preventing chronic conditions. Founded in 2019 and headquartered in Los Angeles, the company partners with employers to enhance employee health and reduce medical expenses. FULLFILL's evidence-based programs have demonstrated significant effectiveness, achieving double the medical results of competing programs and tenfold employee sign-up rates. The platform offers a comprehensive range of resources, including daily videos, podcasts, articles, workouts, and meal plans, all accessible online with 24/7 support from trained Master Coaches. FULLFILL's approach not only addresses issues like obesity, diabetes, and mental health but also boosts participation in other health initiatives offered by employers, while its services qualify as a medical expense. The program has garnered high satisfaction ratings, positioning it as a valuable tool for employee retention amid increasing health challenges, especially in the wake of COVID-19.
Conversa Health
Series B in 2021
Conversa Health, Inc. specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare teams. The company's flagship offering, the Conversa Virtual Care and Communication Platform, streamlines patient engagement and improves health outcomes through automated, personalized messaging based on comprehensive patient profiles derived from electronic health records, biometric devices, and self-reported data. This platform enables health systems, pharmaceutical companies, and payers to shift from reactive communication to proactive engagement, facilitating better management of chronic conditions, acute discharges, and preventive care. Conversa also provides Digital Checkups, which generate tailored clinical questions and alerts based on individual patient data, and Conversa Connect, a patient profiling and health signals engine. Established in 2013 and headquartered in Portland, Oregon, with additional offices in New York, North Carolina, and California, Conversa Health serves a diverse clientele, including healthcare providers, health systems, and health technology companies.
Ellipsis Health
Seed Round in 2021
Ellipsis Health, Inc. is a technology company based in San Francisco, California, founded in 2013. It specializes in developing analytics solutions that utilize artificial intelligence to enhance behavioral health assessments by analyzing patient speech and clinical data. The company's platform offers a behavioral biomarker technology that generates clinical-grade evaluations of anxiety and depression severity, as well as sub-clinical assessments of stress. This innovative approach allows healthcare systems to continuously monitor their patient populations for mental health conditions, particularly depression, and facilitates timely support for patients in need. By integrating affective computing into patient and care team interactions, Ellipsis Health aims to create real-time behavioral health vital signs for improved patient outcomes.
Centivo
Series B in 2020
Centivo Corporation is a health insurance provider that specializes in offering innovative health plans for self-funded employers, employees, and clinicians. Established in 2016 and headquartered in Stamford, Connecticut, with additional offices in New York and Buffalo, Centivo serves as an alternative to traditional insurance carriers and third-party administrators. The company integrates technology, network management, claims processing, and customer support to effectively administer health benefits. Centivo emphasizes collaboration between employees and their primary care teams to coordinate healthcare needs, encouraging members to engage in high-value care through personalized matching tools and a user-friendly app. By focusing on controlling costs and improving navigation through the healthcare system, Centivo positions itself as a dedicated partner to employers, ensuring accountability and minimizing waste in healthcare spending.
harbor
Seed Round in 2020
Harbor is a Los Angeles-based company established in 2019 that specializes in retailing public safety equipment and offering disaster preparedness and planning services. The company has developed an app and readiness platform designed to simplify the assessment of preparedness needs and enhance personal safety. By curating expert advice and personalizing the experience, Harbor aims to automate and gamify critical aspects of home safety. This innovative approach seeks to make disaster readiness an engaging and integral part of daily life, ultimately providing users with peace of mind in the face of unexpected events.
Brio
Seed Round in 2020
Brio Systems, Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in COVID-19 testing solutions for workplaces. Its comprehensive platform offers on-site PCR and antibody testing, logistical support, medical oversight, and digital results communication within three days. Brio connects employers with a network of FDA-certified labs, serving industries such as manufacturing and food processing. The company's secure platform also provides diagnostic testing services for individuals, focusing on blood metrics like sugar and hormone levels, offered on a monthly subscription basis.
Oobli
Series A in 2020
Oobli specializes in the development of healthy, protein-based sweeteners sourced from exotic plants. These unique compounds offer a flavorful experience without the calories typically associated with sugar, making them a suitable alternative for health-conscious consumers. The protein sweeteners are produced through fermentation, ensuring they have no glycemic impact and do not disrupt the gut microbiome. Oobli has successfully obtained regulatory approvals, including FDA "no questions" letters and GRAS status for several of its proteins, reinforcing their commitment to safety and quality. By providing a delicious and low-calorie option, Oobli aims to transform the way individuals approach sweeteners, allowing for healthier choices in everyday consumption.
Hydrow
Venture Round in 2020
Hydrow Inc., established in 2017 and based in Cambridge, Massachusetts, specializes in manufacturing high-end virtual rowing machines for home workouts. The company's flagship product, Hydrow, offers users an immersive rowing experience akin to being on the water, complete with adjustable resistance, real-time visuals, and audio, guided by expert instructors via on-demand digital courses. Hydrow sells its products directly to consumers through its online platform.
Conversa Health
Venture Round in 2020
Conversa Health, Inc. specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare teams. The company's flagship offering, the Conversa Virtual Care and Communication Platform, streamlines patient engagement and improves health outcomes through automated, personalized messaging based on comprehensive patient profiles derived from electronic health records, biometric devices, and self-reported data. This platform enables health systems, pharmaceutical companies, and payers to shift from reactive communication to proactive engagement, facilitating better management of chronic conditions, acute discharges, and preventive care. Conversa also provides Digital Checkups, which generate tailored clinical questions and alerts based on individual patient data, and Conversa Connect, a patient profiling and health signals engine. Established in 2013 and headquartered in Portland, Oregon, with additional offices in New York, North Carolina, and California, Conversa Health serves a diverse clientele, including healthcare providers, health systems, and health technology companies.
Conversa Health
Series B in 2020
Conversa Health, Inc. specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare teams. The company's flagship offering, the Conversa Virtual Care and Communication Platform, streamlines patient engagement and improves health outcomes through automated, personalized messaging based on comprehensive patient profiles derived from electronic health records, biometric devices, and self-reported data. This platform enables health systems, pharmaceutical companies, and payers to shift from reactive communication to proactive engagement, facilitating better management of chronic conditions, acute discharges, and preventive care. Conversa also provides Digital Checkups, which generate tailored clinical questions and alerts based on individual patient data, and Conversa Connect, a patient profiling and health signals engine. Established in 2013 and headquartered in Portland, Oregon, with additional offices in New York, North Carolina, and California, Conversa Health serves a diverse clientele, including healthcare providers, health systems, and health technology companies.
Better Life Partners
Series A in 2020
Better Life Partners Inc. is a healthcare provider based in Hanover, New Hampshire, focused on supporting individuals struggling with opioid use disorder in the United States. Established in 2018, the company offers a range of services including medication-assisted treatment, counseling, peer coaching, and group sessions. Better Life Partners utilizes technology to create personalized care plans that adapt to clients' needs, ensuring effective healthcare delivery through telehealth and community-based solutions. By integrating medical and behavioral healthcare, the company aims to address the complex needs of patients, providing comprehensive support to help them recover from addiction. Better Life Partners has additional offices across various locations in New Hampshire, reflecting its commitment to serving vulnerable populations.
Brio
Venture Round in 2020
Brio Systems, Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in COVID-19 testing solutions for workplaces. Its comprehensive platform offers on-site PCR and antibody testing, logistical support, medical oversight, and digital results communication within three days. Brio connects employers with a network of FDA-certified labs, serving industries such as manufacturing and food processing. The company's secure platform also provides diagnostic testing services for individuals, focusing on blood metrics like sugar and hormone levels, offered on a monthly subscription basis.
Oura
Series B in 2020
Oura is a Finnish company that specializes in the development of a smart wellness ring designed to monitor and track various biometric data related to health and well-being. The ring incorporates advanced sensors to measure key metrics such as heart rate, sleep cycles, and activity levels, providing users with insights into their physiological and behavioral responses to sleep, rest, and recovery. This data is accessible through the accompanying Oura application, which enables users to understand their overall health status and make informed lifestyle choices. Oura operates within the health and wellness industry, focusing on enhancing the user's understanding of their body and promoting better health outcomes.
Moons
Seed Round in 2020
Moons is a healthcare technology company based in Mexico City that specializes in orthodontic and dental hygiene products. Founded in 2019, the company offers innovative dental services, including the creation of personalized invisible aligners designed for each patient. Customers can visit Moons Studios for an initial consultation, where their teeth are scanned to develop a tailored treatment plan. Moons then manufactures and mails a set of 3D-printed aligners, allowing clients to straighten and whiten their teeth without the use of traditional braces. This process typically enables patients to achieve their desired smile in approximately six months, making orthodontic care more accessible and convenient.
Oura
Series B in 2019
Oura is a Finnish company that specializes in the development of a smart wellness ring designed to monitor and track various biometric data related to health and well-being. The ring incorporates advanced sensors to measure key metrics such as heart rate, sleep cycles, and activity levels, providing users with insights into their physiological and behavioral responses to sleep, rest, and recovery. This data is accessible through the accompanying Oura application, which enables users to understand their overall health status and make informed lifestyle choices. Oura operates within the health and wellness industry, focusing on enhancing the user's understanding of their body and promoting better health outcomes.
NeuroFlow
Series A in 2019
NeuroFlow, Inc. is a digital health company that develops a cloud-based platform designed to enhance access to behavioral health and engage patients throughout the continuum of mental healthcare. Founded in 2016 and headquartered in Philadelphia, Pennsylvania, NeuroFlow provides healthcare providers with tools for remote patient monitoring and integration of behavioral health across various care settings, including psychology, primary care, and pain management. The platform employs evidence-based practices to track, assess, and engage patients, promoting overall wellness and improving compliance with treatment. By utilizing patient-generated questionnaires and journaling, NeuroFlow enables individuals to monitor their mental health outcomes and achieve tangible progress. The company has established strategic partnerships with organizations like Smart Health Innovation Lab and Mental Health America to further its mission of improving mental health support and outcomes.
Allevi
Series A in 2019
Allevi develops innovative tools for designing and engineering 3D tissues, focusing on bioprinting technology. The company offers desktop 3D bioprinters that allow users to create functional three-dimensional living tissues using various biomaterials and cell lines. Additionally, Allevi provides bioinks made from collagen and hyaluronic acid, which are available for purchase online. Their cloud-based platform, Bioprint Online, enables users to design complex structures, define materials, and monitor the printing process. Allevi's products serve a diverse clientele, including researchers in tissue engineering, regenerative medicine, and cell biology, as well as industrial and pharmaceutical companies for drug testing and development, and educators. Established in 2014 and based in Philadelphia, Pennsylvania, Allevi was formerly known as BioBots, Inc.
Olaris
Venture Round in 2019
Olaris is dedicated to transforming disease diagnosis and treatment through its innovative CEREBRO platform, which integrates metabolomics and machine learning. This platform focuses on the Comprehensive Early Responsive Evaluation of Biomarkers Related to Outcomes, enabling the identification of biomarkers that can optimize patient treatment. By developing the myOLARIS™ precision diagnostics, Olaris aims to match the right drug to the right patient, enhancing clinical outcomes while minimizing adverse events. Founded in 2013 and headquartered in Framingham, Massachusetts, the company collaborates with healthcare providers to improve patient care through advanced diagnostic solutions.
Vincere Health
Venture Round in 2019
Vincere Health Inc. is a health technology company based in Allston, Massachusetts, founded in 2019 at the Harvard Innovation Labs. The company has developed a mobile application aimed at assisting users in quitting smoking and making healthier choices through a combination of behavioral nudges, incentives, and evidence-based interventions. Users can set personal health goals and test their adherence by using an attachable breathalyzer device to track their smoking habits daily. The platform offers immediate financial rewards for users who reduce their smoking and ultimately quit. Additionally, Vincere Health provides personalized coaching and real-time progress tracking to support chronic disease management and promote healthier lifestyle choices, addressing significant healthcare challenges primarily focused on smoking cessation.
E25Bio
Seed Round in 2019
E25Bio Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing rapid diagnostic tests for epidemic fever viruses, including dengue, chikungunya, and Zika. Founded in 2018, the company specializes in paper-based diagnostic systems that enable swift detection of viral antigens produced during infections. Its innovative platform allows for real-time data reporting through a mobile application, which captures results along with information on test timing and location. This approach aims to facilitate epidemiologic predictions and disease mapping, ultimately assisting governments and health organizations in managing outbreaks effectively and preventing public health crises. E25Bio's solutions are designed to provide affordable and timely diagnostics at the point of care.
Brave Care
Seed Round in 2019
Brave Care, Inc. specializes in urgent pediatric health care services, treating a wide range of conditions, including allergies, asthma, cough, ear pain, eye issues, fever, minor fractures, and rashes. The company also offers pediatric-specific laboratory services, on-site x-ray, and light sedation for certain procedures. Founded in 2019 and based in Portland, Oregon, Brave Care operates clinics exclusively designed for children in Oregon and Texas. In addition to in-person care, the BraveCare.com website and mobile app provide nationwide pediatric advice to assist parents in supporting their children's health and development.
Motif
Series A in 2019
Motif develops plant-based food products designed to produce healthy food using genetic engineering and fermentation. Their food technologies enable CPG companies to develop plant-based alternatives that have the same meaty taste, appearance, and texture as their animal counterparts. They offer bioprocessing services, finished products, and food services.
Mahmee
Seed Round in 2019
Mahmee is an integrated care delivery platform focused on improving maternal and infant health. The company aims to address the critical gaps in the U.S. healthcare system, which faces high maternity costs and mortality rates, particularly among Black mothers and infants. By building a digital infrastructure that connects patients, independent health professionals, and healthcare organizations, Mahmee enhances access to comprehensive prenatal and postpartum care. Its platform includes a care management system that links health records for mothers and babies, flags clinical risks, and facilitates collaboration among maternity and infant care practitioners. Additionally, Mahmee’s marketplace allows new and expecting parents to discover care providers and access services both in-person and virtually, thereby supporting better health outcomes for families.
AdaptX
Venture Round in 2019
AdaptX is a healthcare data analytics and AI company that specializes in enhancing clinical and workflow outcomes for hospitals and surgery centers. Founded in Seattle in 2016 as a spin-off from Seattle Children's Hospital, AdaptX provides a platform that enables medical leaders and clinicians to access and analyze clinical data effectively. The platform integrates algorithms with existing electronic data systems, allowing healthcare providers to monitor performance, compare treatment approaches, and define patient cohorts. Through automated analytics, AdaptX helps healthcare service providers improve the quality and safety of care while also reducing costs.
Hydrow
Series A in 2019
Hydrow Inc., established in 2017 and based in Cambridge, Massachusetts, specializes in manufacturing high-end virtual rowing machines for home workouts. The company's flagship product, Hydrow, offers users an immersive rowing experience akin to being on the water, complete with adjustable resistance, real-time visuals, and audio, guided by expert instructors via on-demand digital courses. Hydrow sells its products directly to consumers through its online platform.
Allevi
Venture Round in 2019
Allevi develops innovative tools for designing and engineering 3D tissues, focusing on bioprinting technology. The company offers desktop 3D bioprinters that allow users to create functional three-dimensional living tissues using various biomaterials and cell lines. Additionally, Allevi provides bioinks made from collagen and hyaluronic acid, which are available for purchase online. Their cloud-based platform, Bioprint Online, enables users to design complex structures, define materials, and monitor the printing process. Allevi's products serve a diverse clientele, including researchers in tissue engineering, regenerative medicine, and cell biology, as well as industrial and pharmaceutical companies for drug testing and development, and educators. Established in 2014 and based in Philadelphia, Pennsylvania, Allevi was formerly known as BioBots, Inc.
Apprentice Health
Seed Round in 2018
Apprentice Health is a predictive analytics firm focused on enhancing the efficiency of healthcare systems through its comprehensive operations platform. Based in Boston, Massachusetts, the company aims to facilitate the transition to value-based care by identifying inefficiencies in workflows within clinics and hospitals. Its platform provides actionable recommendations for improving scheduling, staffing, and facility utilization. By addressing these areas, Apprentice Health helps healthcare providers increase patient access, enhance the patient experience, and alleviate clinical staff burnout. The firm was founded by Rajiv Sivendran and Artur Menzeleev, emphasizing a commitment to higher patient and staff satisfaction while also reducing operational costs.
AVA
Venture Round in 2018
AVA is a developer of a lightweight health device that monitors and filters pollutants. Its health device uses air quality sensors to filter small particles, which can be charged using a USB port and regulated through an application with the increasing levels of air impurities that enable users to protect themselves from specific pollutant details that can negatively affect their health.
NeuroFlow
Venture Round in 2018
NeuroFlow, Inc. is a digital health company that develops a cloud-based platform designed to enhance access to behavioral health and engage patients throughout the continuum of mental healthcare. Founded in 2016 and headquartered in Philadelphia, Pennsylvania, NeuroFlow provides healthcare providers with tools for remote patient monitoring and integration of behavioral health across various care settings, including psychology, primary care, and pain management. The platform employs evidence-based practices to track, assess, and engage patients, promoting overall wellness and improving compliance with treatment. By utilizing patient-generated questionnaires and journaling, NeuroFlow enables individuals to monitor their mental health outcomes and achieve tangible progress. The company has established strategic partnerships with organizations like Smart Health Innovation Lab and Mental Health America to further its mission of improving mental health support and outcomes.
Eva
Venture Round in 2018
Higia Technologies, founded in 2016 and based in Mexico City, develops EVA, a wearable device aimed at assessing breast cancer risk. This non-invasive device features tactile sensors that map the breast's surface and surrounding areas, enabling women to monitor changes in breast temperature, size, and weight. Equipped with biosensors, EVA continuously tracks relevant information, providing users with accessible tools for breast health management.
Farcast
Series C in 2018
Farcast Biosciences, established in 2019, is a clinical diagnostic company based in Boston, Massachusetts, with a lab in Bangalore, India. The company specializes in developing and utilizing a proprietary Human Tumor Micro Dynamics (HTMD) platform. This platform preserves the tumor microenvironment using fresh, unmodified human tumor fragments and autologous blood samples, enabling oncologists and drug developers to test individual tumors and predict patient response to treatments with higher accuracy. Farcast's mission is to illuminate personalized treatment paths for cancer patients by providing precise, patient-specific data.
Lumiata
Series B in 2018
Lumiata Inc. specializes in predictive health analytics tailored for risk-bearing organizations, including hospital networks and insurance carriers. Founded in 2013 and based in San Mateo, California, the company has developed a medical graph that organizes and analyzes diverse healthcare data, enabling real-time predictive analytics. Its flagship product, The Lumiata Risk Matrix, provides personalized predictions regarding individual health changes, supported by a chain of medical reasoning. By leveraging over 120 million patient records and proprietary clinical knowledge, Lumiata's machine learning tools empower healthcare providers and payers to enhance decision-making, manage costs, and improve patient care. The company serves a range of clients, including payers, population health organizations, and digital health companies, facilitating applications in underwriting and care management while prioritizing member privacy.
Bainbridge Health
Seed Round in 2018
Bainbridge Health, Inc. is a Philadelphia-based company that develops a clinical intelligence and data analytics platform focused on improving medication safety in hospital systems. Founded in 2016, the company provides solutions specifically for medication safety leaders, including an infusion pump management software known as InfusionWare. This platform allows clinicians to manage infusion data centrally, enhancing patient safety by streamlining data handling and reducing the likelihood of medication errors. Bainbridge Health’s vendor-agnostic approach eliminates the need for cumbersome data management practices, enabling hospitals to mitigate risks associated with medication errors while also lowering avoidable costs.
RubiconMD
Series B in 2018
RubiconMD, Inc. operates an online platform that facilitates communication between primary care clinicians and specialists through its eConsult service. This platform allows primary care providers to seek expert guidance on medical cases, thereby enhancing patient care and reducing healthcare costs. In addition to the eConsult service, RubiconMD offers a continuing medical education (CME) program for eConsult submissions, live and on-demand webinars, and RubiconRx, a clinical pharmacy platform that supports patient medication access. The company also provides support in electronic health records, workflow integration, onboarding, and clinician engagement. Founded in 2013 and headquartered in New York, RubiconMD serves a diverse clientele, including employers, community health centers, correctional health facilities, health plans, and direct primary care practices.
DOTS
Venture Round in 2018
DOTS Technology Corp, founded in 2013 and located in Natick, Massachusetts, operates a diagnostic platform designed to assist consumers with food allergies. The company is focused on developing a food allergen detection system that allows users to test food on the spot, providing immediate information to enhance decision-making and improve the overall quality of life for individuals affected by food allergies. By advancing point-of-care detection technology, DOTS aims to address the needs of millions of consumers and has applications in both consumer and industrial sectors.
AVA
Series A in 2018
AVA is a developer of a lightweight health device that monitors and filters pollutants. Its health device uses air quality sensors to filter small particles, which can be charged using a USB port and regulated through an application with the increasing levels of air impurities that enable users to protect themselves from specific pollutant details that can negatively affect their health.
RubiconMD
Series B in 2018
RubiconMD, Inc. operates an online platform that facilitates communication between primary care clinicians and specialists through its eConsult service. This platform allows primary care providers to seek expert guidance on medical cases, thereby enhancing patient care and reducing healthcare costs. In addition to the eConsult service, RubiconMD offers a continuing medical education (CME) program for eConsult submissions, live and on-demand webinars, and RubiconRx, a clinical pharmacy platform that supports patient medication access. The company also provides support in electronic health records, workflow integration, onboarding, and clinician engagement. Founded in 2013 and headquartered in New York, RubiconMD serves a diverse clientele, including employers, community health centers, correctional health facilities, health plans, and direct primary care practices.
ActiveProtective
Series A in 2018
ActiveProtective is a consumer device company that produces smart garments to reduce traumatic injury using wearable airbag technology. The company's proprietary technology uses 3D motion sensors to determine the stereotypical motions and accelerations that govern the body’s normal, daily activities, in order to determine ’departures’ from what is allowable. This technique called "fall disambiguation", allows users to determine falls prior to impact, intercept hip fractures, and protect themselves from risks during sports and military sessions by deploying micro-airbag protection. ActiveProtective was founded in 2006 and is based in Allentown, Pennsylvania.
Center Health
Seed Round in 2018
Center Health focuses on advancing diabetes management through innovative technology. The company has developed an AI-driven assistant and a connected blood sugar meter that allows users to monitor their glucose levels effectively. This device not only facilitates real-time tracking of blood sugar but also helps users maintain records and analyze how daily activities influence their glucose levels. By promoting simple logging and collaboration, Center Health aims to provide personalized insights, enhancing the overall experience for individuals managing diabetes. Ultimately, the company's goal is to empower patients to take control of their health and improve their quality of life.
Lumiata
Series A in 2017
Lumiata Inc. specializes in predictive health analytics tailored for risk-bearing organizations, including hospital networks and insurance carriers. Founded in 2013 and based in San Mateo, California, the company has developed a medical graph that organizes and analyzes diverse healthcare data, enabling real-time predictive analytics. Its flagship product, The Lumiata Risk Matrix, provides personalized predictions regarding individual health changes, supported by a chain of medical reasoning. By leveraging over 120 million patient records and proprietary clinical knowledge, Lumiata's machine learning tools empower healthcare providers and payers to enhance decision-making, manage costs, and improve patient care. The company serves a range of clients, including payers, population health organizations, and digital health companies, facilitating applications in underwriting and care management while prioritizing member privacy.
NeuroFlow
Seed Round in 2017
NeuroFlow, Inc. is a digital health company that develops a cloud-based platform designed to enhance access to behavioral health and engage patients throughout the continuum of mental healthcare. Founded in 2016 and headquartered in Philadelphia, Pennsylvania, NeuroFlow provides healthcare providers with tools for remote patient monitoring and integration of behavioral health across various care settings, including psychology, primary care, and pain management. The platform employs evidence-based practices to track, assess, and engage patients, promoting overall wellness and improving compliance with treatment. By utilizing patient-generated questionnaires and journaling, NeuroFlow enables individuals to monitor their mental health outcomes and achieve tangible progress. The company has established strategic partnerships with organizations like Smart Health Innovation Lab and Mental Health America to further its mission of improving mental health support and outcomes.
NewLeaf Symbiotics
Series C in 2017
NewLeaf Symbiotics, Inc. is an agriculture technology company based in Saint Louis, Missouri, dedicated to the research, development, and commercialization of beneficial symbiotic bacteria aimed at enhancing plant health and increasing crop yields. The company focuses on naturally occurring bacteria, particularly pink pigmented facultative methylotrophs, which are utilized across various agricultural sectors, including row crops, vegetables, fruits, and ornamental plants. NewLeaf Symbiotics conducts extensive laboratory, greenhouse, and field trials to validate the effectiveness of its products, providing farmers with sustainable solutions to combat plant diseases and improve agricultural productivity. Originally founded as TrophoMax, LLC in 2011, the company rebranded in July 2012 to better reflect its mission and objectives in the agricultural biotechnology space.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.